Mutya Harsch left the role of Chief Legal Officer and General Counsel at VYNE Therapeutics on July 27, 2026, according to an SEC filing.
| Name | Mutya Harsch |
|---|---|
| Role | Chief Legal Officer and General Counsel |
| Company | VYNE Therapeutics |
| Industry | Biotech |
| Location | New Haven, CT |
| Move | Departure |
| Date | July 27, 2026 |
| Source | an SEC filing |
Mutya Harsch stepped down as Chief Legal Officer and General Counsel of VYNE Therapeutics when the company’s merger closed in July 2026, with her employment ending July 27. The combined company now operates as Yarrow Bioscience, and her exit was treated as a change-in-control termination without cause. (Source: an SEC filing.)
Other general counsel moves in July 2026
- Sylvia Kerrigan Steps Down as Senior Vice President and Chief Legal Officer of Occidental (July 31, 2026)
- Brad Pollack Named Senior Vice President and General Counsel of Occidental (July 31, 2026)
- Wm. Gordon Prescott Steps Down as General Counsel and Corporate Secretary of Beacon Financial (July 31, 2026)
- Courtney Nelson Wills Steps Down as Senior Vice President, General Counsel and Corporate Secretary of MiniMed Group (July 30, 2026)
- Alan J. Glass Steps Down as Vice President, Chief Legal Officer and Secretary of Standex International (July 30, 2026)
- Erin Abrams Steps Down as Chief Legal Officer of Via Transportation (July 27, 2026)
- Matt Levine Named Chief Legal Officer of Via Transportation (July 27, 2026)
- Mary Mabey Steps Down as Senior Vice President and General Counsel of ATN International (July 27, 2026)
Planning your own next move?
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.